Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL339957 | 0.84 | TSHR (0.33) | CA2MAPK1TSHRTDP1 | |
| SCHEMBL4263532 | 0.83 | — | — | |
| Acetic Acid SCHEMBL29229984 | 0.74 | TSHR (0.41) | ALDH1A1TSHRTDP1 | |
| SCHEMBL5611403 | 0.73 | CA2 (0.40) | CA2MAPK1ALDH1A1TSHR | |
| SCHEMBL28013434 | 0.72 | PGD (0.32) | — | |
| SCHEMBL4531236 | 0.71 | SMN1; SMN2 (0.35) | CA2MAPK1ALDH1A1TSHRTDP1 | |
| 2-Ethylhexanoic Acid SCHEMBL22069985 | 0.70 | CA2 (0.71) | CA2MAPK1ALDH1A1TDP1 | |
| SCHEMBL27573194 | 0.70 | CA2 (0.38) | CA2MAPK1ALDH1A1TSHRTDP1 | |
| SCHEMBL28678611 | 0.70 | CA2 (0.38) | CA2MAPK1ALDH1A1TSHRTDP1 | |
| SCHEMBL2631146 | 0.69 | CA2 (0.41) | CA2MAPK1ALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 799 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3755675-B1 | ACCELERATED PEROXIDE-CURED RESIN COMPOSITIONS HAVING EXTENDED OPEN TIMES | ARKEMA INC (US) | 2026-05-13 | — | — | EP | claimed |
| US-20260027750-A1 | Continuous Extruder Process for Manufacturing Rheology-Modified Polyolefin for Cable Insulation Layer, and Related Products | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-29 | — | — | US | claimed |
| US-20250353938-A1 | DYNAMICALLY CROSSLINKED POLYOLEFIN PRODUCED THROUGH A POST-REACTOR PROCESS WITH A DYNAMIC DISULFIDE CROSSLINKER | BRASKEM AMERICA INC (US) | 2025-11-20 | — | — | US | claimed |
| US-20250346695-A1 | ETHYLENE BASED CO/TERPOLYMERS CONTAINING A HIGH PURITY -S-S- BASED DYNAMIC CROSSLINKER TO PRODUCE AN IN-REACTOR DYNAMIC MATERIAL | BRASKEM AMERICA INC (US) | 2025-11-13 | — | — | US | claimed |
| WO-2025235568-A1 | ETHYLENE BASED CO/TERPOLYMERS CONTAINING A HIGH PURITY -S-S- BASED DYNAMIC CROSSLINKER TO PRODUCE AN IN-REACTOR DYNAMIC MATERIAL | BRASKEM AMERICA, INC. (US) | 2025-11-13 | — | — | WO | claimed |
| US-20250257190-A1 | COMPOSITION COMPRISING AT LEAST ONE DIALKYL OR PEROXYKETAL PEROXIDE AND AT LEAST ONE UNSATURATED ORGANIC PEROXIDE | ARKEMA FRANCE (FR) | 2025-08-14 | — | — | US | claimed |
| US-20250092251-A1 | MULTIPHASED POLYHYDROXYALKANOATE-BASED COMPOSITIONS AND ARTICLES MADE THEREFROM | NEWLIGHT TECHNOLOGIES, INC. | 2025-03-20 | — | — | US | claimed |
| EP-4479475-A2 | MULTIPHASED POLYHYDROXYALKANOATE-BASED COMPOSITIONS AND ARTICLES MADE THEREFROM | Newlight Technologies, Inc. (US) | 2024-12-25 | — | — | EP | claimed |
| EP-4426781-A1 | COMPOSITION COMPRISING AT LEAST ONE DIALKYL OR PEROXYKETAL PEROXIDE AND AT LEAST ONE UNSATURATED ORGANIC PEROXIDE | ARKEMA FRANCE (FR) | 2024-09-11 | — | — | EP | claimed |
| WO-2024062201-A1 | COMPOSITION COMPRISING AT LEAST ONE DIALKYL OR PEROXYKETAL PEROXIDE AND AT LEAST ONE UNSATURATED ORGANIC PEROXIDE | ARKEMA FRANCE (FR) | 2024-03-28 | — | — | WO | claimed |
| EP-0774474-A2 | Higher heat styrenics | Nova Chemicals (International) SA (CH) | 1997-05-21 | — | — | EP | claimed |
| EP-0768156-A2 | Process for polymer degradation | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1997-04-16 | — | — | EP | claimed |
| US-5587434-A | DEPOLYMERIZATION BY ADDING A FREE RADICAL GENERATOR; PROCESS CONTROL | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1996-12-24 | — | — | US | claimed |
| EP-0423639-B1 | Peroxide masterbatches using polycaprolactone as the carrier | ATOCHEM NORTH AMERICA (US) | 1995-09-20 | — | — | EP | claimed |
| EP-0504920-A2 | Scorch retarding curing/crosslinking compositions | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1992-09-23 | — | — | EP | claimed |
| EP-0259537-B1 | PROCESS FOR REDUCING RESIDUAL MONOMERS IN LOW VISCOSITY POLYMER-POLYOLS | ATOCHEM NORTH AMERICA, INC. (a Pennsylvania corp.) (US) | 1992-03-25 | — | — | EP | claimed |
| EP-0273090-B1 | SOLUTION POLYMERIZATION OF ACRYLIC ACID DERIVED MONOMERS USING TERTIARY ALKYL( C5)-HYDROPEROXIDES | ATOCHEM NORTH AMERICA, INC. (a Pennsylvania corp.) (US) | 1992-03-18 | — | — | EP | claimed |
| US-4808656-A | CURED ACRYLIC COPOLYMERS; HARD, NON-DISCOLORING; AUTOMOBILES | PPG INDUSTRIES, INC. (US) | 1989-02-28 | — | — | US | claimed |
| US-4804775-A | USING SYNERGISTIC MIXTURE OF PEROXYCARBONATE, DIPEROXYKETAL AND PEROXYESTER CHASER CATALYST | PENNWALT CORPORATION (US) | 1989-02-14 | — | — | US | claimed |
| EP-0259537-A2 | Process for reducing residual monomers in low viscosity polymer-polyols | ATOCHEM NORTH AMERICA, INC. (a Pennsylvania corp.) (US) | 1988-03-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027750-A1 | Continuous Extruder Process for Manufacturing Rheology-Modified Polyolefin for Cable Insulation Layer, and Related Products | SEC16A, RBM17, IDE | CA2 4668/4885MAPK1 593/4885ALDH1A1 1730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.